 |
 including Molecular Interventions
Editor-in-Chief:
R. Waksman MD
See editorial board for all editors information
Description
Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original
laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.
Cardiovascular Revascularization
Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological
interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in
vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart
disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes
research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.
Cardiovascular Revascularization
Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with
the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special
features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and
interesting images are encouraged.
| Bibliographic details |
ISSN: 1553-8389
Imprint: ELSEVIER
Subscriptions for the year 2009,
Volume 10,
4 issues |
| Price and Ordering |
Institutional price:
USD 265
|
Personal price:
USD 129
|
Single issue price:
USD 67
|
Personal price USA:
USD 111
|
Institutional price USA:
USD 233
|
Conditions of sale & ordering procedures.
|
066/681
Last update: 2 Oct 2008
|
|
| |
